je.st
news
Merck KGaA brain tumor drug fails clinical trial
2013-02-25 15:33:17| Biotech - Topix.net
Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's efforts to replenish its pipeline of medicines.
Tags: trial
drug
clinical
brain
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||